FOR IMMEDIATE RELEASE                                                           FEB 07, 2007

Contact: Glen Gordon MD 360-297-6858

EM-PROBE Technologies EMpulse nominated for INDEX Award  


Port Gamble, WA – Honored by the Arlington Institute of Wash DC as a nominee for the prestigious INDEX Award, EM-PROBE Technologies of Kitsap Co was recently notified its EMpulse SOLO technology passed first review, and along with other nominees, continues the rigorous scrutiny by the INDEX committee of international design experts en route to capturing the $100,000 INDEX award and recognition as “a design to improve life for mankind”.

Sponsored by the Danish government, and awarded in Copenhagen, INDEX seeks market disruptive concepts and designs to solve global challenges. In greatly enhancing tissue restoration following trauma, SOLO sets the standard for electromagnetic restoration devices via miniaturization, nanosecond circuitry, safety, and efficacy-the fastest, lightest device in the world. No larger than a cell phone, SOLO equals moderate doses of morphine for pain relief, and dramatically accelerates tissue restoration following trauma or inflammation. Replacing devices weighing hundreds of pounds, persons of any age or disability can self-administer SOLO after major illness, trauma, and surgery. Disaster aid workers can carry SOLO on their person anywhere in the world to provide 50 consecutive hours of treatment for pain or trauma using only a 9v battery. EMpulse SOLO- “stands alone for pain or trauma.” Dr. Glen Gordon, the founder of EM-PROBE Technologies, was the original investigator of nanosecond designs in the US, and is now considered a “senior spokesman” for this technology.

About EM-PROBE Technologies

Sports medicine specialist and researcher, Dr. Glen Gordon founded EM-PROBE Technologies in 2001. Dr. Gordon, the first MD in the United States approved to treat humans with soft tissue injury and arthritis using nanosecond pulsed electromagnetic field technology, chaired the first symposium on free radical damage in sports injury presented at an annual meeting of The American College of Sports Medicine. An invited speaker at a 2006 W.H.O. international meeting on integrative medicine, he conducts research on his company's miniaturized, FDA-approved, hand held device, the result of 25 years of research and development. The company also provides information on PEMF technology and clinical studies through its Web site. For more information about EM-PROBE Technologies, please visit www.em-probe.com, or call 1-888-697-9996.